Literature DB >> 7058043

Investigation of circulating immune complexes in patients with breast cancer.

M Horváth, B Fekete, P Rahóty.   

Abstract

Circulating immune-complex (IC) levels of patients with breast cancer were measured before and after surgery using a complement-consumption technique. 16 of 26 patients showed raised pre-operative IC values. In 15 out of 16 patients the pathological IC levels decreased within 2--10 days following surgery. Suggestions about the applicability of this test not only for prognosis, but also for monitoring the course of breast cancer need to be confirmed by further investigations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058043     DOI: 10.1159/000225597

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.

Authors:  M Radhakrishna Pillai; P Balaram; N K Hareendran; S Bindu; T Abraham; T K Padmanabhan; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Secondary immune thrombocytopenic purpura with renal cell carcinoma.

Authors:  Shigeaki Nakazawa; Masataka Kawamura; Kosuke Nakano; Norichika Ueda; Hidefumi Kishikawa; Hirokazu Kashiwagi; Motohide Uemura; Ryoichi Imamura; Kenji Nishimura; Norio Nonomura
Journal:  IJU Case Rep       Date:  2019-08-02

3.  Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.

Authors:  R K Gupta; A M Leitch; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Idiopathic thrombocytopenic purpura in women with breast cancer.

Authors:  Mozhgan Alam Samimi; Nooshin Mirkheshti; Mitra Heidarpour; Mozhgan Abdollahi
Journal:  J Res Med Sci       Date:  2010-11       Impact factor: 1.852

5.  Prognostic significance of circulating immune complexes in cancer patients.

Authors:  T K Dass; M Aziz; A Rattan
Journal:  Jpn J Cancer Res       Date:  1991-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.